Dataset Information

Environmental signals act as a driving force for metabolic and defense responses in the Antarctic plant Colobanthus quitensis

ABSTRACT: Due to the progressive environmental change that the Antarctic Peninsula has undergone over time, a more comprehensive overview of the metabolic features of Colobanthus quitensis becomes particularly interesting to assess its ability to respond to environmental stresses. To this end, a differential proteomic approach has been used to study the response of C. quitensis to different environmental cues.

INSTRUMENT(S): Orbitrap Eclipse

ORGANISM(S): Colobanthus Quitensis

TISSUE(S): Leaf

SUBMITTER: Aleš Holfeld

LAB HEAD: Carla Caruso

PROVIDER: PXD037324 | Pride | 2023-03-11

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	210409_EC1_molivotto_S1R1.raw	Raw
	210409_EC1_molivotto_S1R2.raw	Raw
	210409_EC1_molivotto_S1R3.raw	Raw
	210409_EC1_molivotto_S2R1.raw	Raw
	210409_EC1_molivotto_S2R2.raw	Raw

Items per page:

1 - 5 of 18

Publications

Environmental Signals Act as a Driving Force for Metabolic and Defense Responses in the Antarctic Plant <i>Colobanthus quitensis</i>.

Bertini Laura L Proietti Silvia S Fongaro Benedetta B Holfeld Aleš A Picotti Paola P Falconieri Gaia Salvatore GS Bizzarri Elisabetta E Capaldi Gloria G Polverino de Laureto Patrizia P Caruso Carla C

Plants (Basel, Switzerland) 20221121 22

During evolution, plants have faced countless stresses of both biotic and abiotic nature developing very effective mechanisms able to perceive and counteract adverse signals. The biggest challenge is the ability to fine-tune the trade-off between plant growth and stress resistance. The Antarctic plant <i>Colobanthus quitensis</i> has managed to survive the adverse environmental conditions of the white continent and can be considered a wonderful example of adaptation to prohibitive conditions for ...[more]

PMID: 36432905

Similar Datasets

Project description:Sepsis is the major cause of mortality across intensive care units globally, yet details of accompanying pathological molecular events are unclear. This has resulted in ineffective development of sepsis-specific biomarkers and therapies, and suboptimal treatment regimens in preventing and reversing organ damage. Here, we used pharmacoproteomics to score treatment effects in a preclinical Escherichia coli sepsis model based on changes in the organ, cell, and plasma proteome landscapes. A combination of pathophysiological read-outs and time-resolved proteome maps of organs and blood enabled the definition of time-dependent and organotypic proteotypes of dysfunction and damage that was used to guide the administration of several combinations of beta-lactam antibiotic meropenem and immunomodulatory glucocorticoid methylprednisolone. The proteome-based scoring strategy revealed three distinct response patterns defined as intervention-specific reversions, non-reversions, and specific intervention-induced effects, revealing that the intervention effects depended on the underlying proteotype and varied significantly between organs. In the later stages of the disease, administration of glucocorticoids accentuated some of the positive effects exerted by Mem leading to superior reduction of the inflammatory response in the kidneys and partial restoration of the metabolic dysfunction instigated by sepsis. Unexpectedly, antibiotics introduced sepsis-independent perturbations in the mitochondrial proteome that was to some degree counteracted by glucocorticoids. In summary, this study provides a pharmacoproteomic resource describing the time-resolved septic organ failure landscape across organs and the blood compartment, and a novel scoring strategy that captures unintended secondary drug effects as an important criterion to consider while assessing therapeutic efficacy. Such information is critically important to enable a quantitative, objective and organotypic assessment of treatment benefits and unintended effects, drug synergies of candidate treatments as well as the effect of dose and time in murine sepsis models.